BLISS GVS PHARMA LTD Financial Ratios
BLISSGVS · Healthcare · Current price ₹483.5
P/E ratio
39.6x
P/B ratio
4.7x
ROE
11.8%
ROCE
17.0%
Debt / Equity
0.02
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 39.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 11.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.02 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with BLISS GVS PHARMA LTD's latest numbers.
BLISS GVS PHARMA LTD profitability
BLISS GVS PHARMA LTD generates a return on equity of 11.8% and a return on capital employed of 17.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.02 and a P/E of 39.6x, BLISS GVS PHARMA LTD is conservatively financed. Our overall business-quality score for the company is 4.3 / 10.
Understand the ratios
More on BLISS GVS PHARMA LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.